ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Pace® Aerobiology Receives AIHA EMLAP Accreditation for Washington State Laboratory

Company adds bacteria, E. coli, Legionella, and other microbiology testing and analysis capabilities to support the Northwest United States

Aerobiology, part of the Pace® Analytical Services laboratory network, today announced that its Seattle, Washington, laboratory has achieved accreditation from the American Industrial Hygiene Association (AIHA) for its Environmental Microbiology Laboratory Accreditation Program (EMLAP).

The mission of the AIHA is to establish high standards for laboratories to produce quality data for making decisions that impact public health, the environment, and natural resources. The association manages several accreditation programs, including EMLAP, which was developed specifically for microbiology labs providing microbiology testing of air, fluids, and bulk samples collected from various sources including schools, hospitals, and work environments.

"Pace® is committed to meeting the needs of our customers for high-quality, cost-effective analytical services. This accreditation ensures our customers meet their regulatory requirements on their important projects," notes Greg Whitman, president of Pace® Analytical Services.

As a result of this achievement, the Pace® Aerobiology Seattle lab may now analyze culture samples for bacteria, fungi, and non-viable analysis of spore trap and tape/wipe direct samples. These analyses include the detection of Legionella, Mycobacteria, and Pseudomonas. This lab also performs screen tests on sewage to identify E. coli and fecal coliforms. The company's deep expertise in bacterial and fungal testing in environmental and clinical settings is backed by over 25 years of industry experience. Within the Pace® nationwide network of over 100 laboratories and service centers, 11 are Pace® Aerobiology locations offering microbiology testing and analysis capabilities.

Pace® is a portfolio company of Leonard Green & Partners and Los Angeles-based Aurora Capital Partners.

About Pace® Aerobiology

For more than 25 years, Pace® Aerobiology has provided microbial indoor air quality and related laboratory services. As part of the Pace® nationwide network of labs and service centers, the business now provides microbiology services for environmental and clinical settings through 11 locations. Pace® Aerobiology labs are accredited by the Environmental Microbiology Laboratory Accreditation Program (EMLAP), the Centers for Disease Control (CDC) ELITE Program, the National Voluntary Laboratory Accreditation Program (NVLAP), and the American Industrial Hygiene Association (AIHA). More at Aerobiology.net.

About Pace®

Pace® makes the world a safer, healthier place. For decades, Pace® people have been committed to advancing the science of the pharmaceutical and biotechnology industries in our Life Sciences laboratories and supporting businesses, industries, consulting firms, government agencies, and more through our Analytical Services laboratories. Pace® offers local-level service backed by a national laboratory network. For customers with in-house labs, Pace® provides a range of professional services to keep their operations moving forward. Pace® people work in partnership with customers by providing the service, science, and the data they need to make critical decisions that benefit us all. More at PaceLabs.com.

Contact Information:
Pam Bednar
Marketing Director
pam.bednar@pacelabs.com
612-297-0651


Original Source: Pace® Aerobiology Receives AIHA EMLAP Accreditation for Washington State Laboratory
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.